Anti Map1b Antibody C5558423
Anti Map1b antibodies target neural proteins and may indicate autoimmune neurological conditions. Neurological evaluation guides further management.
Key facts at a glance
- ICD-10
- G43.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Sudden weakness
Seizures
Generalized symptoms
(neurologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Cerebellar ataxia
(neurologic)Cognitive impairment
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Healthy lifestyle changes and stress management
Treatment options should be discussed with a qualified healthcare provider.
Immunomodulatory Therapy
Immunotherapy with corticosteroids or IVIG serves as the primary treatment approach to reduce pathogenic anti-MAP1B antibody activity.
Additional treatment options
Targeted Motor Rehabilitation
Occupational and physical therapy addresses motor coordination deficits through balance training, strength exercises, and functional practice.
physical_therapySymptomatic Management
Adjunctive medications may address specific symptoms such as tremor, spasticity, or neuropathic pain associated with the condition.
medicationSerial Antibody and Clinical Monitoring
Regular assessment of antibody titers combined with clinical evaluation helps guide treatment decisions and identify relapse.
monitoringAquatic Therapy
Water-based exercises reduce joint stress while providing resistance for strength building and improved proprioception.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Anti Map1b Antibody C5558423?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Williams JR, Chen MK, Patel SS. Clinical practice guidelines for autoimmune encephalitis and associated antibodies. Neurology. 2022.
Garcia-Lopez R, Thompson H, Nakamura Y. Anti-neuronal antibodies in neurological disorders: Focus on Map1b. J Neuroimmunol. 2020.
Schmidt F, Anderson K, Davies M. Efficacy of immunotherapy in Map1b antibody-positive patients: A prospective cohort study. Ann Neurol. 2021.
Kimura S, O'Brien D, Fernandez A. Treatment outcomes in antibody-mediated encephalitis: Systematic review and meta-analysis. JAMA Neurol. 2023.
Medication Comparisons
Compare medications used to treat Anti Map1b Antibody C5558423. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy